PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsFluoroquinolone
Fluoroquinolone
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
1133 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Healthy volunteers/patients———1822—35192
InfectionsD007239EFO_0000544—916334332132
Urinary tract infectionsD014552EFO_0003103N39.04718201058
Communicable diseasesD003141——4717131556
TuberculosisD014376EFO_0000774A15-A19723191852
PneumoniaD011014EFO_0003106J18172013949
Pulmonary tuberculosisD014397EFO_1000049A15118193337
Chronic obstructive pulmonary diseaseD029424EFO_0000341J44.910585328
Bacterial infectionsD001424—A495295728
Helicobacter infectionsD016481EFO_1000961—1—613727
Show 157 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
SepsisD018805EFO_0001420A41.9——5—914
Hiv infectionsD015658EFO_0000764B20612—211
Otitis externaD010032EFO_0009560H60147——11
Crohn diseaseD003424EFO_0000384K50—71—210
Acquired immunodeficiency syndromeD000163EFO_0000765B207—2—110
UlcerD014456MPATH_579—143—29
KeratitisD007634—H16—15—28
Community-acquired infectionsD017714———35——8
LymphomaD008223—C85.92—4—17
Extensively drug-resistant tuberculosisD054908———55—17
Show 123 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
PharmacokineticsD010599——111——113
AnthraxD000881—A2222——37
Escherichia coli infectionsD004927EFO_1001318B96.2032——15
MyopiaD009216EFO_0003927H52.121——35
Infectious arthritisD001170EFO_1001351M00—1——34
SarcoidosisD012507EFO_0000690D80-D8922———3
EaracheD004433—H92.013———3
Ear diseasesD004427EFO_1001455H93.913———3
Otorhinolaryngologic diseasesD010038——13———3
Parkinson diseaseD010300EFO_0002508G2021———3
Show 40 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
SchizophreniaD012559EFO_0000692F205———16
Type 2 diabetes mellitusD003924EFO_0001360E114———15
Long qt syndromeD008133HP_0001657I45.813———25
Hepatitis cD006526—B19.25————5
Alzheimer diseaseD000544EFO_0000249F034————4
Heart failureD006333EFO_0003144I502———13
HypertensionD006973EFO_0000537I102———13
PainD010146EFO_0003843R522———13
RegenerationD012038——1———23
AnemiaD000740EFO_0004272D64.93————3
Show 89 more
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Staphylococcal infectionsD013203—A49.01————55
PeritonitisD010538EFO_0008588K65————55
Ischemic strokeD000083242——————33
Bacterial drug resistanceD024881——————22
Staphylococcus aureusD013211NCBITaxon_1280—————22
Rectal fistulaD012003—K60.3————22
AstigmatismD001251EFO_0004222H52.2————22
Pathologic dilatationD004108——————22
Drug monitoringD016903——————22
Deglutition disordersD003680—R13.1————22
Show 83 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name—
INN—
Description
—
Classification
Unknown
Drug class—
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)—
Identifiers
PDB—
CAS-ID—
RxCUI—
ChEMBL ID—
ChEBI ID—
PubChem CID—
DrugBank—
UNII ID—
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
46 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use